165 related articles for article (PubMed ID: 10482423)
1. Immunosuppression and reactivation of hepatitis B in the lamivudine era: opportunities for prevention and exploitation?
Farrell GC
J Gastroenterol Hepatol; 1999 Aug; 14(8):741-4. PubMed ID: 10482423
[No Abstract] [Full Text] [Related]
2. Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy.
Maguire CM; Crawford DH; Hourigan LF; Clouston AD; Walpole ET; Powell EE
J Gastroenterol Hepatol; 1999 Aug; 14(8):801-3. PubMed ID: 10482432
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy for chronic hepatitis B.
Schalm SW
J Hepatol; 2003; 39 Suppl 1():S146-50. PubMed ID: 14708694
[No Abstract] [Full Text] [Related]
4. [Lamivudine treatment for hepatitis B].
Lamivudine Clincal Practice Group
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
[No Abstract] [Full Text] [Related]
5. Chronic hepatitis B.
Lok AS
N Engl J Med; 2002 May; 346(22):1682-3. PubMed ID: 12037146
[No Abstract] [Full Text] [Related]
6. Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
Cooksley G
Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):12-3. PubMed ID: 16265091
[No Abstract] [Full Text] [Related]
7. Treatment of hepatitis B e antigen-negative chronic hepatitis B with lamivudine.
Rizzetto M; Marzano A; Lagget M
J Hepatol; 2003; 39 Suppl 1():S168-71. PubMed ID: 14708698
[No Abstract] [Full Text] [Related]
8. [New antiviral agent. Hepatitis B therapy with slight resistance risk].
MMW Fortschr Med; 2003 Dec; 145(51-52):40. PubMed ID: 14974332
[No Abstract] [Full Text] [Related]
9. [Factors predicting the disappearance of virus B replication markers following treatment with lamivudine].
Buffet C
Presse Med; 2003 Jan; 32(2):53-4. PubMed ID: 12653025
[No Abstract] [Full Text] [Related]
10. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.
Yeo W; Steinberg JL; Tam JS; Chan PK; Leung NW; Lam KC; Mok TS; Johnson PJ
J Med Virol; 1999 Nov; 59(3):263-9. PubMed ID: 10502254
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients.
Lim LL; Wai CT; Lee YM; Kong HL; Lim R; Koay E; Lim SG
Aliment Pharmacol Ther; 2002 Nov; 16(11):1939-44. PubMed ID: 12390103
[TBL] [Abstract][Full Text] [Related]
12. [Chronic hepatitis B].
Kumada H
Nihon Shokakibyo Gakkai Zasshi; 2001 May; 98(5):503-11. PubMed ID: 11400278
[No Abstract] [Full Text] [Related]
13. Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues.
Wong GL; Chan HL; Lo AO; Chan HY; Tse CH; Chim AM; Wong VW
Antivir Ther; 2013; 18(8):979-86. PubMed ID: 23744529
[TBL] [Abstract][Full Text] [Related]
14. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
Peters MG; Hann Hw Hw; Martin P; Heathcote EJ; Buggisch P; Rubin R; Bourliere M; Kowdley K; Trepo C; Gray Df Df; Sullivan M; Kleber K; Ebrahimi R; Xiong S; Brosgart CL
Gastroenterology; 2004 Jan; 126(1):91-101. PubMed ID: 14699491
[TBL] [Abstract][Full Text] [Related]
15. [Evidence based antiviral therapy for chronic hepatitis B].
Okanoue T; Minami M
Nihon Shokakibyo Gakkai Zasshi; 2005 Oct; 102(10):1253-8. PubMed ID: 16262155
[No Abstract] [Full Text] [Related]
16. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.
Perrillo R; Hann HW; Mutimer D; Willems B; Leung N; Lee WM; Moorat A; Gardner S; Woessner M; Bourne E; Brosgart CL; Schiff E
Gastroenterology; 2004 Jan; 126(1):81-90. PubMed ID: 14699490
[TBL] [Abstract][Full Text] [Related]
17. [Current treatment of hepatitis B].
Suárez García E; Romero Gómez M; Grande Santamaría L
Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
[No Abstract] [Full Text] [Related]
18. Lamivudine for chronic hepatitis B and HIV co-infection.
Carton JA; Maradona JA; Asensi V; Rodríguez M; Martínez A
AIDS; 1999 May; 13(8):1002-3. PubMed ID: 10371189
[No Abstract] [Full Text] [Related]
19. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
[TBL] [Abstract][Full Text] [Related]
20. Case report: dramatic response to lamivudine therapy following corticosteroid priming in chronic hepatitis B.
Liaw YF; Chien RN
J Gastroenterol Hepatol; 1999 Aug; 14(8):804-6. PubMed ID: 10482433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
